ZONEONE PHARMA INC has a total of 33 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, chemical engineering and organic fine chemistry are LIU AIGUO, MA JIA and HENAN UNIV OF TRADITIONAL CHINESE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Singapore | 2 | |
#8 | Republic of Korea | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Organic fine chemistry | |
#4 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Chemical or physical processes | |
#3 | Heterocyclic compounds | |
#4 | Containers for goods storage |
# | Name | Total Patents |
---|---|---|
#1 | Hayes Mark E | 31 |
#2 | Noble Charles O | 31 |
#3 | Szoka Jr Francis C | 14 |
#4 | Szoka Francis C Jr | 13 |
#5 | Szoka Francis C | 4 |
#6 | Dai Zhipeng | 1 |
#7 | Szoka Jr | 1 |
#8 | Francis C Jr Szoka | 1 |
#9 | Mark E Hayes | 1 |
#10 | Charles O Noble | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018005963A1 | Synthesis of new methylumbelliferone prodrugs and their incorporation into lipid-based drug delivery formulations | |
WO2016025559A1 | Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systems | |
WO2016025611A2 | Pharmaceutical formulations of chelating agents as a metal removal treatment system | |
AU2015301234A1 | Remote loading of sparingly water-soluble drugs into lipid vesicles | |
CA2906794A1 | Pharmaceutical formulations of chelating agents as a metal removal treatment system | |
WO2014121235A2 | Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes | |
EP2950784A2 | Remote loading of sparingly water-soluble drugs into liposomes |